According to the latest PMR forecasts, included in the report “Dietary supplements market in Poland 2020. Development forecasts for 2020-2025”, the sale of dietary supplements in Poland in pharmacies and outside of them (in shops, at petrol stations and all other retail outlets, including e.g. gyms) will increase by 2.6% in 2020 to reach almost PLN 6bn in retail prices*.
Pharmacy sales are a growth driver
The sale of dietary supplements in pharmacies, which were not closed during the lockdown period, is the driving force behind market growth – especially in March 2020, when historically record increases were recorded. At the same time, we estimate that the value of non-pharmacy sales in 2020 will fall by 1% (in the baseline scenario). As far as the categories of supplements are concerned, immune-boosting products and used during infection products, as well as vitamins and minerals, will be best sold.
Increased health awareness as a major positive effect of the coronavirus pandemic
The factor that could most influence the development of the food supplement market is, again as in the previous edition of the survey, consumer awareness of these products. At present, the belief that people in the face of the coronavirus pandemic will be more prophylactic, which will also manifest itself in the use of dietary supplements, was supported by a survey conducted by PMR among 100 companies present on the dietary supplements market in Poland.
As many as one third of the respondents indicate a factor of economic recovery – this is understandable in view of the forecasts for 2020, which assume an economic recession. As a result of falling sales, more companies than in previous editions of the survey also count on intensified marketing activities and external financial assistance, e.g. from the EU.
Among the areas requiring legal regulations, the respondents mentioned:
- rules for placing dietary supplements on the market
- rules on advertising
- adjustment of Polish regulations to EU regulations
- provisions aimed at reducing employer costs
- customs regulations
- provisions concerning the composition of food supplements – authorised substances and their doses.

Other factors mentioned by the companies that could affect the development of their business are:
- end of the pandemic, return of patients to pharmacies
- good, qualified staff
- minimising manufacturing costs
- decrease in exchange rate
- looking for alternative methods to health care
- becoming independent from the Chinese market
- social campaigns to improve the image of food supplements.
* according to one of the scenarios presented in the report, i.e. the baseline scenario assuming a relatively constant number of COVID-19 cases by the end of the year and no return to restrictions
You can read more about the impact of the coronavirus pandemic on the market of dietary supplements and the prospects for its development in the latest PMR report: “Dietary supplements market in Poland 2020. Market analysis and development forecasts for 2020-2025”.
AUTHOR
Monika Stefańczyk
Pharma and Healthcare Business Unit Director
MEDIA CONTACT
marketing@pmrcorporate.com
Tel. +48 12 34 05 135
Recent posts

PMR’s report: Poles cut down on expenses but fashion does not come first
PMR’s estimates indicate that in 2022 the market will record growth again, mainly on the back of increased demand for…

PMR: PLN 58bn online sales of services in 2022
Data from the latest PMR report “Online retail of services in Poland 2022. E-commerce market analysis and development forecasts for…

PMR: Record-breaking cosmetics market growth in 2022
PMR forecasts that in 2022 the cosmetics market in Poland will grow by 6.1% YoY, to around PLN 27.7bn. This…

PMR Hospital Outcomes Index highest for private hospitals
The situation on the hospital market over the last 10 years was at its worst in autumn 2020, according to…

PMR: Ready-to-eat meals market in Poland is stable in difficult times
The ready-to-eat meals market in Poland is growing rapidly, being in a relatively early phase of development. In 2021, this…

PMR: Value of pharmaceutical distribution in Poland reached PLN 56bn in 2021
According to the latest PMR report “Distribution on the pharmaceutical market in Poland 2022. Market analysis and development forecasts for…

